RS

Ruchi Sharma

Active Director Director DIN 10888068
DIN 10888068 First appointment Dec 2024 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Ruchi Sharma

Data last updated:

Ruchi Sharma is a Director at Xiphoid Pharmaceuticals Private Limited (since 2024). The company operates in Trading.

DIN 10888068
Primary Designation Director
Industry Trading
First Appointment 27 Dec 2024
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Dec 20242022Active

Directorship timeline

Open interactive timeline →
Xiphoid Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ruchi Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ruchi Sharma

Ruchi Sharma currently holds 1 directorship: Xiphoid Pharmaceuticals Private Limited (Director, since 27 Dec 2024).

Ruchi Sharma was first appointed on 27 Dec 2024 as Director at Xiphoid Pharmaceuticals Private Limited.

The current boards of Ruchi Sharma's companies include Ashvin Nathabhai Parsana (Xiphoid Pharmaceuticals Private Limited), Dilipbhai Laxmanbhai Dudhagara (Xiphoid Pharmaceuticals Private Limited), Dimpalben Sanjaybhai Chovatiya (Xiphoid Pharmaceuticals Private Limited), Kanchan Ashwinbhai Parsana (Xiphoid Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available